Dxone S 500mg/250mg Injection
Marketer
Dr. D Pharma
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Dxone S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance. Complete the prescribed regimen, even with symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Allergic reactions (skin rashes, pruritus, edema, dyspnea) necessitate urgent medical assistance. Inform your physician of all concurrent medications prior to commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption is contraindicated due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Monitoring may involve laboratory tests to assess the medication's effects.
Primary Ingredients of Dxone S 500mg/250mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Dxone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Dxone S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Dxone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Dxone S 500mg/250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Dxone S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Dxone S 500mg/250mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Dxone S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Dxone S, 500mg/250mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Dxone S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Dxone S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Dxone S 500mg/250mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
The injectable medication, Dxone S 500mg/250mg, requires careful administration to individuals with significant hepatic impairment. Dosage modification may be necessary; physician consultation is advised. Altering the dosage of Dxone S 500mg/250mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Dxone S 500mg/250mg Injection :
Omit a Dxone S 500mg/250mg Injection dose? Seek your physician's advice.
Facts to Know About Dxone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently